LD2F.0

ICD-11 MMS 2026-01

Toxic or drug-related embryofetopathies

Exclusions from above levels

  • http://id.who.int/icd/entity/733825440 – Inborn errors of metabolism

Child codes

  • LD2F.00 – Fetal alcohol syndrome
  • LD2F.01 – Fetal hydantoin syndrome
  • LD2F.02 – Embryofetopathy due to oral anticoagulant therapy
  • LD2F.03 – Fetal Valproate Spectrum Disorder
  • LD2F.0Y – Other specified toxic or drug-related embryofetopathies
  • LD2F.0Z – Toxic or drug-related embryofetopathies, unspecified

Foundation children elsewhere

  • LB44.6 – Uterovaginal malformation due to diethylstilbestrol syndrome

Sibling codes

  • LD2F.1 – Syndromes with multiple structural anomalies, not of environmental origin
  • LD2F.Y – Other specified syndromes with multiple structural anomalies, without predominant body system involvement
  • LD2F.Z – Syndromes with multiple structural anomalies, without predominant body system involvement, unspecified

Foundation entity

Toxic or drug-related embryofetopathies – http://id.who.int/icd/entity/293076727

Allowed postcoordination axes

Part of: LD2F: Syndromes with multiple structural anomalies, without predominant body system involvement › 20: Developmental anomalies